“%s”的搜索结果，显示 321-330 项，共有 953 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Frailty is thought to be mediated by senescent cells and their dynamic secretome, referred to as the senescence-associated secretory phenotype (SASP). Senescent ...

2. 乳腺癌- 医生与科室- 妙佑医疗国际

   以下医生姓氏开头为S S · 以下医生姓氏开头为T T; 没有医生姓氏开头为U U; 以下医生姓氏开头为V V · 以下医生姓氏开头为W W; 没有医生姓氏开头为X X; 没有医生姓氏开头为Y ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab and ...

4. 乳腺癌- 医生与科室- 妙佑医疗国际

   以下医生姓氏开头为S S · 以下医生姓氏开头为T T; 没有医生姓氏开头为U U; 以下医生姓氏开头为V V · 以下医生姓氏开头为W W; 没有医生姓氏开头为X X; 没有医生姓氏开头为Y ...

5. 乳腺癌- 医生与科室- 妙佑医疗国际

   显示$起始范围- $结束范围/源自可用$可用医生 · John K. Camoriano, M.D. · Grace M. Choong, M.D. · Saranya Chumsri, M.D. · Gerardo Colon-Otero, M.D. · Kimberly S. Corbin ...

6. 癌症 - 医生与科室- 妙佑医疗国际

   Dan S. Childs, M.D.. Oncologist. Rochester, MN ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab and ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with bendamustine plus MabThera/Rituxan ( ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the association between a baseline comprehensive geriatric assessment (cGA) and chemotherapy toxicity ...

10. 神经科- 临床试验- 妙佑医疗国际

    Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the ...